WASHINGTON DIARY
Tags: SCIENCE; CELERA Genomics Group (Company); NATIONAL Institutes of Health (U.S.); HUMAN genome; PETROLEUM industry -- Environmental aspects
Related Articles
- The revolution has begun. Coghlan, Andy; Le Page, Michael // New Scientist;02/17/2001, Vol. 169 Issue 2278, p4
Discusses controversy regarding the mapping of the human genome. The disputes between publicly-funded Human Genome Project (HGP) and the private company Celera Genomics; Claim of HGP researcher John Sulston that Celera's method is not greatly superior to HGP's draft genome; The HPG's use of...
- Working draft of the human genome completed. Dobson, Roger // Bulletin of the World Health Organization;2000, Vol. 78 Issue 9, p1168
Reports on the compilations of the human genome deoxyribonucleic acid (DNA) from the Human Genome Project and Celera Genomics, a biotechnology company. Coverage of the Human Genome Project; Coordinated work on DNA; Matching of genes with functions and detection of genetic variations; ...
- CELERA DONATES PROTEASE INHIBITOR TO BE DEVELOPED FOR CHAGAS DISEASE. // Clinical Infectious Diseases;4/1/2002, Vol. 34 Issue 7, pii
Reports that the Institute for OneWorld Health and the U.S. National Institutes of Health are developing CRA-3316 cysteine protease inhibitor from Celera Genomics to treat Chagas disease. Information on how the protease inhibitor can treat parasitic infections.
- Researchers Anticipate New Cures. Gribbin, August // Insight on the News;03/26/2001, Vol. 17 Issue 12, p29
Highlights the findings of scientists of the International Human Genome Sequencing Consortium and Celera Genomics Corp. on the human genome. Diseases linked to genes; Similarities of the findings of scientists; Dispute over the methods of genome sequencing.
- Playing God. Cray, Charlie // Multinational Monitor;Oct/Nov99, Vol. 20 Issue 10/11, p4
Features information on the filing of patents on parts of the human genome by a Maryland-based company of Celera Genomics. Views of Andrew Kimbrell, director for the International Center for Technology Assessment, on the human genome patenting; Industry analysts anticipation on the human genome;...
- Human Genome Promise. Venter, J. Craig // R&D Magazine;Jun99, Vol. 41 Issue 7, p40
Offers observation on genomic research. Discussion on human genome sequencing projects of Celera Genomics; Implication of genomic research on human health, medical practice, pharmacogenomics and agriculture; Features of the genomic research of Celera; Information on the other uses of genomic...
- An explosion in technologies spurs new genomic advances. // Hudson Valley Business Journal;07/17/2000, Vol. 11 Issue 12, p11
Reports on the positive impact of the draft of the human genome completed by Celera Genomics and the Human Genome Project. Application of the technology on gene functional analysis; Use of genomics to develop drugs and diagnostics.
- US company claims to have 90% of human genome on its database. Josefson, Deborah // BMJ: British Medical Journal (International Edition);01/22/2000, Vol. 320 Issue 7229, p206
Reports that the United States biotechnology company Celera Genomics has announced that it has the DNA sequence of 90% of the human genome in its databases. Information on the company; Details on the technique used by the company in the human genome project.
- Mapping the Human Genome Is Only the Beginning. Mirasol, Feliza // Chemical Market Reporter;08/21/2000, Vol. 258 Issue 8, pFR8
Reports that genomics companies with business models in providing enabling and support technologies in functional genomics are poised to benefit from the advancements in mapping the human genome. Market capitalization of top 10 genomics companies for the period ended December 31, 1999;...
